Active Pharmaceutical Ingredients
Product Name
CAS Number
Specification
TP
DMF
Status
Hyoscyamine hydrobromide
114-49-8
Q1 2025
Q3 2025
Semaglutide
910463-68-2
Q4 2024
Q2 2025
SNAC
203787-91-1
Q4 2024
Q2 2025
Vincennes
1257044-40-8
Q1 2025
Q3 2025
Perfluorohexyl octane
133331-77-8
Q1 2025
Q3 2025
Apixaban
503612-47-3
In-house
√
Asenapine
65576-45-6
In-house
√
Avatrombopag
570406-98-3
In-house
√
Benzoxonium chloride
19379-90-9
In-house
Q2 2025
Bicyclol
118159-48-1
CP, In-house
√
Calcium Saccharate
5793-89-5
CP, In-house
√
Dapagliflozin
461432-26-8
USP, In-house
√
Efinaconazole
164650-44-6
In-house
√
Eliglustat Tartrate
928659-70-5
In-house
√
Entecavir Monohydrate
209216-23-9
USP, EP, in-house
√
Febuxostat
144060-53-7
In-house
√
Fluvastatin sodium
93957-55-2
CP, USP, EP, JP
√
Galanthamine
357-70-0
EP, In-house
Q3 2025
Lumateperone Tosylate
1187020-80-9
In-house
√
Macitentan
441798-33-0
In-house
√